Showing newest first. Show oldest first.
Or order by title
- Clinical Trial Readiness for the Dystroglycanopathies
Katherine D. Mathews
- Brain Connectivity in Adolescents
Beng Choon Ho
- Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (VAMC)
- Study Patients with Advanced or Metastatic Untreated Soft Tissue Sarcoma
- Antimullerian Hormone Levels in Girls and Adolescents Receiving Gonadotoxic Cancer Therapies
- A multicenter, stratified, open, randomized, comparator-controlled, parallel-group phase III study comparing treatment with 177Lu-DOTA0-Tyr3-Octreotate to...
- Medamacs: The Medical Arm of Mechanical Circulatory Support
- A Phase II Evaluation of Ixabepilone (IND #59699, NSC #710428) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus
- Transfusion of Prematures (TOP) Trial
Edward F. Bell
- A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND #74019, NSC #736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma
- A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children <36 Months Old With Intensive Induction Chemotherapy With Methotrexat…
- Cognitive and Psychiatric Functioning in Adults with Carcinoid Tumors
- Phase III trial of enzalutamide (NSC # 766085) versus enzalutamide, abiraterone and prednisone for castration resistant metastatic prostate cancer
- Randomized Phase II Study Comparing the MET inhibitor Cabozantinib to Temozolomide/Dacarbazine in Ocular Melanoma
- Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc P(1)
- GOG 3001/ Amgen TRINOVA-3 - A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III…
- Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab...
- A Phase III Randomized Trial of Gemcitabine (NSC# 613327) plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) vs. Observation for Uterus-limited, High Grade Uterine Leiomyosarcoma
- A Multicenter Open-Label, Randomized Phase 1b/2, Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Lenalidomide...
- A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.